Acelyrin, Inc.
SLRN
$2.09
-$0.39-15.73%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -81.38% | -37.94% | 31.40% | 160.09% | 1,063.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -82.03% | -53.47% | 117.88% | 97.66% | 1,698.67% |
| Operating Income | 82.03% | 53.47% | -117.88% | -97.66% | -1,698.67% |
| Income Before Tax | 16.99% | 42.16% | -229.01% | 80.18% | -380.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.99% | 42.16% | -229.01% | 80.18% | -380.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.99% | 42.16% | -229.01% | 80.18% | -380.70% |
| EBIT | 82.03% | 53.47% | -117.88% | -97.66% | -1,698.67% |
| EBITDA | 82.07% | 53.56% | -117.67% | -- | -- |
| EPS Basic | 19.23% | 43.88% | -116.38% | 95.85% | 90.30% |
| Normalized Basic EPS | 90.31% | 56.37% | -116.35% | 61.93% | 58.70% |
| EPS Diluted | 19.23% | 43.88% | -116.38% | 95.85% | 90.30% |
| Normalized Diluted EPS | 90.31% | 56.37% | -116.35% | 61.93% | 58.70% |
| Average Basic Shares Outstanding | 2.76% | 3.06% | 52.06% | 377.81% | 4,854.76% |
| Average Diluted Shares Outstanding | 2.76% | 3.06% | 52.06% | 377.81% | 4,854.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |